Alprazolam and Standard Antidepressants in the Treatment of Depression: A Meta-analysis of the Antidepressant Effect

Journal of the Medical Association of Thailand

Volumn 80, Issue 3, 1997, Pages 182-188

  Srisurapanont, Manit ^a   Boonyanaruthee, Vudhichai ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RECEPTOR DOWN REGULATION; STANDARD;

ALPRAZOLAM; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0030806866     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Sethy VH, Hodges DH. Role of beta-adrenergic receptors in the antidepressant activity of alprazolam. Res Commun Chem Pathol Pharmacol 1982; 36: 329-32.
2. Sethy BH, Hodges DH. Alprazolam in a biochemical model of depression. Biochem Pharmacol 1982; 31: 3155-7.
3. Andersch S, Rosenberg NK, Kullingsjo H, et al. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder: a scandinavian multicenter study. Acta Psychiatr Scand Suppl 1991; 365: 18-27.
4. Cross-National Collaborative Panic Study, Second Phase Investigators. Drug treatment of panic disorder: comparative efficacy of alprazolam, imipramine, and placebo. Br J Psychiatry 1992; 160: 191-202.
5. Fabre LF. Pilot open label study with alprazolam (U-31,889) in outpatients with neurotic depression. Current Therapeutic Research 1976; 19: 661-8.
6. Warner MD, Peabody CA, Whiteford HA, Hollister LE. Alprazolam as an antidepressant. J Clin Psychiatry 1988; 49: 148-50.
7. Jonas JM, Cohon MS. A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic, and depression: a review of the literature. J Clin Psychiatry 1993; 54 (10 Suppl.): 25-45.
8. Boulenger J-P, Lavallee Y-J. Mixed anxiety and depression: diagnostic issues. J Clin Psychiatry 1993; 54 (1 Suppl.): 3-8.
9. Klerman GL. Mood disorders. In: A Task Force Report of the American Psychiatric Association ed. Treatment of psychiatric disorders. Washington, DC: American Psychiatric Press, 1989: 1725-2003.
10. American Psychiatric Association. Practice guideline for major depressive disorder in adults. Am J Psychiatry 1993; 150 (4 Suppl.): 1-26.
11. Thacker SB. Meta-analysis: a quantitative approach to research investigation. JAMA 1988; 259: 1685-9.
12. Eriksson B, Nagy A, Starmark J-E, Thelander U. Alprazolam compared to amitriptyline in the treatment of major depression. Acta Psychiatr Scand 1987; 75: 656-63.
13. Banerji JR, Brantingham P, McEvan GD, et al. A comparison of alprazolam with amitriptyline in the treatment of patients with neurotic or reactive depression. Ir J Med Sci 1989; 158: 110-3.
14. Weissman MM, Prusoff B, Sholomskas AJ, Greenwald S. A double-blind clinical trial of alprazolam, imipramine, or placebo in the depressed elderly. J Clin Psychopharmacol 1992; 12: 175-82.
15. Lapierre YD, Browne M, Oyewumi K, Sarantidis D. Alprazolam and amitriptyline in the treatment of moderate depression. Int Clin Psychopharmacol 1994; 9: 41-5.
16. Draper RJ, Daly I. Alprazolam and amitriptyline: a double blind comparison of anxiolytic and antidepressant activity. Ir Med J 1983; 76: 453-6.
17. Ansseau M, Ansoms C, Beckers G, et al. Double-blind clinical study comparing alprazolam and doxepin in primary unipolar depression. J Affect Disord 1984; 7: 287-96.
18. Rickels K, Feighner JP, Smith WT. Alprazolam, amitriptyline, doxepin, and placebo in the treatment of depression. Arch Gen Psychiatry 1985; 42: 134-41.
19. Rush AJ, Erman MK, Schlesser MA, et al. Alprazolam vs amitriptyline in depressions with reduced REM latencies. Arch Gen Psychiatry 1985; 42: 1154-9.
20. Remick RA, Fleming JAE, Buchanan RA, et al. A comparison of the safety and efficacy of alprazolam and desipramine in moderately severe depression. Can J Psychiatry 1985; 30: 597-601.
21. Fawcett J, Edwards JH, Kravitz HM, Jeffriess H. Alprazolam: an antidepressant? alprazolam, desipramine, and an alprazolam-desipramine combination in the treatment of adult depressed outpatients. J Clin Psychopharmacol 1987; 7: 295-310.
22. Rickels K, Chung HR, Csanalosi IB, et al. Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression. Arch Gen Psychiatry 1987; 44: 862-6.
23. Rosenthal R. Meta-analysis: a review. Psychosom Med 1991; 53: 247-71.
24. Wolf FM. Meta-analysis: quantitative methods for research synthesis. Beverly Hills: Sage, 1986.
25. DerSimonian R, Laird N. Meta-analysis in clinical trial. Control Clin Trials 1986; 7: 177-88.
26. Cohen J. Statistical power analysis for the social sciences. 3rd ed. Hillsdale New Jersey: Lawrence Erlbaum Associates, 1988.
27. Simpson GM, Lee H, Cuculic Z, Kellner R. Two dosages of imipramine in hospitalized endogenous and neurotic depressives. Arch Gen Psychiatry 1976; 33: 1093-102.
28. Watt DC, Crammerr JL, Elkes A. Metabolism, anticholinergic effects, and therapeutic outcome of desmethylimipramine in depressive illness. Psychol Med 1972; 2: 397-405.
29. Overall JE, Donachie ND, Faillace LA. Implications of restrictive diagnosis for compliance to antidepressant drug therapy: alprazolam v imipramine. J Clin Psychiatry 1987; 48: 51-4.
30. Singh AN, Nair NPV, Suranyi-Cadotte B, et al. A double blind comparison of alprazolam and amitriptyline hydrochloride in the treatment of nonpsychotic depression. Can J Psychiatry 1988; 33: 218-22.
31. Feighner JP, Aden GC, Fabre LF, Rickels K, Smith WT. Comparison of alprazolam, imipramine, and placebo in the treatment of depression. JAMA 1983; 249: 3057-64.
32. Schatzberg AF, Cole JO. Benzodiazepines in depressive disorders. Arch Gen Psychiatry 1978; 35: 1359-65.
33. Johnson DAW. The use of benzodiazepines in depression. Br J Clin Pharmacol 1985; 19: 31S-5S.